ALKERMES PLC. (ALKS)
Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
HONEYWELL BOARD OF DIRECTORS APPROVES SPIN-OFF OF HONEYWELL AEROSPACE
Sherritt Announces Exclusivity Agreement with Gillon Capital and Appointment of Independent Director
IREN Completes Acquisition of Nostrum Group Expanding AI Cloud Platform to Europe
Enhanced Group Announces $50 Million Strategic Financing Led by Enhanced Co-Founder and Chairman Christian Angermayer; Management Expects Company Fully Funded Through Profitability
American Express Announces Proposed Acquisition of TheFork, a Leading European Restaurant Booking Platform
USA Rare Earth Commissions Hydrometallurgical Demonstration Facility, Targeting Heavy Rare Earth Oxide Production in Third Quarter 2026
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
OTC Markets Group Names Thomas Fasano Head of Broker-Dealer Sales
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia